{
  "environments" : [
      {"theName" : "Psychosis",
      "theShortCode" : "PSY",
      "theDescription" : "The exemplar aims to integrate large existing datasets of serial MRI scans and behaviour data coupled to the NeuroGrid image analysis service into a Grid-based database, test image normalisation techniques, and develop a general ontology for a psychosis databas, for use in multi-centre studies. The exemplar tests capabilities of NeuroGrid to deal with restrospective data, assimilate material into databases, and use of the toolkit for normalisation and analysis."},
      {"theName" : "Stroke",
       "theShortCode" : "STR",
       "theDescription" : "This exemplar aims to improve infrastructure for handling imaging in large studies including: - efficient interpretation and storage of large image datasets from multicentre randomised controlled trials, - very large studies of observer reliability to improve image interpretation, - establishing large living archives of images linked to key metadata for diseases which require long term study to understand their true nature history and the effects of treatment, and - for knowledge transfer."},
      {"theName" : "Core Technology",
       "theShortCode" : "TECH",
       "theDescription" : "NeuroGrid Infrastructure operations"},
      {"Composite_name" : "Complete"},
      {"Duplication" : "Maximise"}
  ],
  "assets" : [
    {
     "theName" : "Clinical Data",
     "theShortCode" : "CD",
     "theDescription" : "None",
     "theSignificance" : "Unanonymised and in the wrong hands, this data can be very damaging.",
     "theType" : "Information",
     "theEnvironmentProperties" :
      [
        ["Psychosis",
         [3,0,2,0,0,0,0,0], 
         ["Researchers very worried about the disclosure of partially anonymised patient data.","None","Availability of NeuroGrid is quite important, but prepared to sacrifice this if doing so safeguards clinical data.","None","None","None","None","None"]
        ],
        ["Stroke",
         [1,0,3,0,0,0,0,0], 
         ["Clinical data is fully anonymised","None","NeuroGrid availability important for clinical trials","None","None","None","None","None"]
        ],
        ["Core Technology",
         [0,0,0,3,0,0,0,0], 
         ["None","None","None","Important for CA to know who is allowed to access what data items.","None","None","None","None"]
        ]
      ]
    }
  ],
  "requirements" : [
    {
      "theName" : "Anonymisation guidelines",
      "theReference" : "Clinical Data",
      "theReferenceType" : "asset",
      "theLabel" : "1",
      "theType" : "Functional",
      "thePriority" : "1",
      "theDescription" : "Anonymisation guidelines shall comply with the MRC guidelines for secure data handlinig and anonymisation.",
      "theRationale" : "None",
      "theFitCriterion" : "None",
      "theOriginator" : "Interview data"
    }
  ]
}
